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Abstract 
BACKGROUND: Thrombus aspiration for ST-segment elevation myocardial infarction (STEMI) may improve 
myocardial perfusion. However, these favourable results called into a question by data indicating not only a lack of 
efficacy but a risk of potentially deleterious complications. 
AIM: To assess the effect of thrombus aspiration during the primary percutaneous coronary intervention (PPCI) 
on procedural angiographic results, stent characteristics, and major adverse cardiac and cerebrovascular events 
(MACCE). 
METHODS: All consecutive STEMI patients candidate for PPCI and admitted to Critical Care Department, Cairo 
University hospitals, managed either by thrombectomy before primary PCI (if thrombus score ≥ 3) or conventional 
PPCI, Six hundred seven subjects were enrolled in the study divided into Group with thrombectomy before PPCI 
(107 subjects, 18%), and group with Conventional PCI (500 subjects, 82%). ST-segment resolution, peak CK-MB, 
TIMI score, thrombus score, and MBG were assessed; stent number, diameter, length and stented segment were 
reported and follow up MACCE was reported (in hospital and 1-year post-intervention). 
RESULTS: Mean values for peak CKMB were less in thrombectomy group (228 ± 174 I/U vs 269 ± 186 I/U, p = 
0.04), ST segment resolution ≥ 70% occurred in {63 subjects (58.9%) vs 233 (46.6%), p = 0.001} in thrombectomy 
vs conventional group respectively. TIMI score pre procedure was zero in (102 subjects (95%) vs 402 (80.4%), p 
= 0.001), while TIMI III post procedure was reported in (100 subjects (93.4%) vs 437 (87%), p = 0.06), MBG mean 
values were (2.4 ± 0.6 vs 2.0 ± 1, p = 0.001), thrombus score was higher in thrombectomy group (4.6 ± 0.4 vs 0.8 
± 1.7, p = 0.001) in thrombectomy vs conventional group respectively .Direct stenting was { 34 patients (31%) vs 
102 patients (20%), p = 0.05} , mean stent diameter (2.7 ± 1.3 mm vs 3.5 ± 1.3 mm, p = 0.3), mean stent length 
was (19.9 mm ± 10 versus 22.7 mm ± 8 in p 0.01). mean stent number was (1.0 ± 0.5 vs 1.2 ± 0.6, p = 0.001), 
mean stented segment was (22.5 ± 13.5 vs 28.5 ± 15.2 mm, p = 0.001) in thrombectomy vs conventional group 
respectively. MACCE in hospital were reported in {9 subjects (8.4%) vs 70 (14%), p = 0.07)}. Follow up MACCE 
after 1 year reported in {6 subjects (5.6 %) vs 80 (16 %), p 0.= 4} in thrombectomy vs conventional group 
respectively. 
CONCLUSION: Thrombus aspiration before primary PCI (in a selected group with thrombus score ≥ 3) improves 
myocardial perfusion, suggested by better ST-segment resolution, TIMI flow, less peak CKMB and MBG, 
associated with a higher rate of direct stenting, shorter stent length, stented segments and less number of stents. 
Although thrombus aspiration was done in more risky patients (higher thrombus score) MACCE (in hospital and 1 
year follow up) showed no statistical difference. 
 
 
 
 
Introduction 
 
Although PCI has become established as the 
dominant reperfusion strategy for the treatment of 
STEMI, its benefit is sometimes limited. Possible 
explanations for this limited benefit have included 
delays in reperfusion and reperfusion injury. Thus, 
reperfusion injury has become a topic of great 
interest, and it has been recognised that thrombus 
burden and embolic debris, thrombus and 
atherosclerotic plaque might be important contributors 
[1].  
Improved flow is associated with improved 
indicators of reperfusion, including ST-segment 
resolution. Infarction size was found to be smaller in 
patients who underwent thrombectomy before stenting 
compared with controls who underwent stenting 
without prior thrombectomy. Finally, thrombectomy is 
associated with improved clinical outcomes and 
survival [2], [3].  
A recent study showed no benefit of 
thrombectomy, perhaps unsurprisingly, when PCI was 
performed late after symptom onset [4]. In addition to 
the possibility that thrombus removal is not beneficial, 
several other possible explanations for the absence of 
benefit observed in these trials should be considered. 
Managed coronaries may have contained only a small 
thrombus burden, as observed in the TOTAL 
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(ThrOmbecTomy versus PCI ALone) optical 
coherence tomography substudy [5]. It is also possible 
that infarction was nearly complete when PCI was 
performed, limiting the possible benefit of any 
intervention, including thrombectomy.  
In this study, we aimed to perform a 
comprehensive analysis to evaluate the outcomes 
associated with aspiration thrombectomy in terms of 
myocardial perfusion, stent characteristics, and major 
adverse cardiac and cerebrovascular events 
(MACCE). 
 
 
Patients and Methods 
 
This was a prospective case-control 
investigational single-centre study involved 607 
patients and included all patients admitted to the 
Critical Care Department of Cairo University Hospitals 
“presenting with ST-segment elevation myocardial 
infarction (STEMI) and subjected to primary 
percutaneous coronary intervention (PCI).”  
The total study group included 607 subjects. 
The subjects were classified into two groups 
according to the use of thrombus aspiration devices: 
A) Group I: Included 107 subjects who 
underwent PCI with thrombus aspiration. 
B) Group II: Included 500 subjects who 
underwent PCI without thrombus aspiration.  
 
Inclusion criteria 
We included all adult patients who presented 
with acute STEMI and fulfilled the following criteria: 
- Prolonged ischemic chest pain (lasting > 30 
minutes). 
- ECG: ST segment elevation (> 1 mm) in 2 or 
more contiguous leads or ECG findings suggestive of 
posterior infarction [6].  
- Presentation ≤ 24 hours from symptom 
onset. 
 
Exclusion criteria 
- Patients with acute in-stent thrombosis 
following elective PCI resulting in STEMI. 
- Any contraindication for primary angioplasty 
or antiplatelet therapy. 
- Patients with missing or incomplete data 
records. 
- Previous CABG. 
Methods 
 
A) Following admission, all patients 
underwent the following: 
- Full medical history and demographic 
characteristics collection. 
- Detailed clinical examination on admission 
(with the determination of Killip class) [7].
 
 
- Collection of written informed consent 
entailing all ethical and moral considerations, as 
requested by the medical council of the Cairo 
University Hospitals. 
B) Demographic data on admission and 
medical history: 
- Age and gender, risk factors for coronary 
artery disease (CAD); the presence of DM [8], 
dyslipidemia [9], or hypertension [10]; smoking history; 
and positive family history for CAD [11], prior PCI.
 
C) Twelve-lead electrocardiogram (ECG): 
- ECG was performed before the intervention, 
1 h post-intervention, and then daily during the 
hospital stay and whenever indicated. 
ST-segment resolution (STR) 
- ST-segment resolution was classified as 
complete (if the resolution was more than 70%), 
partial (if the resolution was between 30% and 70%), 
or absent (if the resolution was less than 30%) [12], 
[13].  
D) Laboratory investigations: 
- Cardiac enzymes (CK-MB) were examined 
on admission, 6 hours and 24 hours after intervention, 
and when needed. 
E) Diagnostic coronary angiography and PCI: 
- The procedures were performed using the 
Integris H 3000 (Philips, NL) catheterisation 
laboratory. 
- Identification of infarct-related artery (IRA) 
and the site of occlusion (Ostial, proximal, mid-
segment or distal).  
- Pain-to-door time, total ischemic time, and 
procedural time. 
- Determination of TIMI flow grading before 
and after the procedure 
- Determination of TIMI thrombus grade: 
- To more objectively and quantitatively 
characterise thrombus on a coronary angiogram, TIMI 
study group developed and popularised the 
following thrombus grading system [14]:  
 TIMI Thrombus Grade 0: No cine 
angiographic characteristics of thrombus present. 
Samy et al. To Whom Thrombus Aspiration May Concern? 
_______________________________________________________________________________________________________________________________ 
_______________________________________________________________________________________________________________________________ 
Open Access Maced J Med Sci.                                                                                                                                                                                                         3 
 
 TIMI Thrombus Grade 1: Hazy, 
possible thrombus present. Angiography 
demonstrates characteristics such as reduced 
contrast density, haziness, irregular lesion contour, or 
a smooth convex "meniscus" at the site of total 
occlusion suggestive but not diagnostic of thrombus. 
 TIMI Thrombus Grade 2: 
Thrombus present – small size: Definite thrombus with 
greatest dimensions less than or equal to 1/2 vessel 
diameter. 
 TIMI Thrombus Grade 3: 
Thrombus present – moderate size: 
Definite thrombus but with a greatest linear dimension 
greater than 1/2 but less than 2 vessel diameters. 
 TIMI Thrombus Grade 4: 
Thrombus present – large size: As in Grade 3 
but with the largest dimension greater than or equal to 
2 vessel diameters. 
 TIMI Thrombus Grade 5: Recent total 
occlusion can involve some collateralization but 
usually does not involve extensive collateralization, 
tends to have a “beak” shape and a hazy edge or 
appearance of distinct thrombus. 
 F) Major adverse cardiac events (MACCE), 
defined as the composite of the following factors: - 
Target vessel revascularisation, acute coronary 
syndromes, death, and Stroke (clinical and/or 
radiological evidence of CVS); - Follow up MACCE 
was assessed in hospital and after 1 year.  
 
Statistical analysis 
Data were collected and coded before 
analysis using the professional Statistical Package for 
Social Sciences (SPSS 18). All data are expressed as 
the mean and standard deviation (SD). - Frequency 
tables were used for all categorical data. - Student’s t-
test (unpaired) was used for all continuous data after 
checking normality. - The Mann-Whitney test was 
used when the standard deviation value was violated. 
- The chi-square test was used for all categorical data 
to test for the presence of an association. For small 
samples, Fisher’s exact test was used. - A P value < 
0.05 was considered significant. 
 
 
Results 
 
This was a prospective case-control 
investigational single-centre study; conducted on 
subjects admitted with (STEMI) and were subjected to 
primary percutaneous coronary interventions. 
The total study group included 607 subjects. 
The subjects were classified into two groups 
according to the use of thrombus aspiration devices: 
Group I: Included 107 subjects who 
underwent PPCI with thrombus aspiration. 
Group II: Included 500 subjects who 
underwent PCI without thrombus aspiration.  
 
Demographics and comorbidities 
The mean age was 57.3 ± 11 years in total 
subjects, (56 ± 10 vs 57 ± 11 years, p = 0.3) in group I 
vs group II respectively. The majority were males 488 
(80.3%) of the total study group (85% vs; 79%, P = 
0.3) in group I vs group II respectively. 
Table 1: Demographics and comorbidities  
 Total Group I Group II P Value 
No. % No. % No. % 
Male gender 488 80.3 92 85 397 79 0.3 
Family history of IHD 197 32 39 36 158 31 0.1 
Smoking 395 65 79 73 316 63 0.2 
Hypertension 296 48 44 41 252 50 0.5 
Diabetes Mellitus 222 36 41 38 181 36 0.3 
Dyslipidemia 213 35 46 43 167 33 0.3 
IHD: ischemic heart disease. 
 
 Myocardial perfusion and angiographic 
 parameters 
A) TIMI score: 
- TIMI score pre-procedure was zero in (95% 
vs 80%, p 0.001) in group I vs group II respectively 
Table 2. 
- TIMI III post procedure occurred in (93% vs 
87% P: 0.07) while TIMI zero post procedure occurred 
in (0.9% vs 2.2%, P = 0.07) in group I vs group II 
respectively. 
Table 2: Clinical characteristics for the study group 
 All subjects 
Mean ± SD 
Group I 
Mean ± SD 
Group II 
Mean ± SD 
p-value 
Age 57.3 ± 11 56 ± 10 57 ± 11 0.3 
Heart rate (HR) (BPM) 86 ± 16 83 ± 16 87 ± 16 0.3 
MAP /mmHg 71 ± 12 73 ± 11 71 ± 12 0.1 
 PDT /h 5.1 ± 2.6 5.1 ± 2.8 5.1 ± 2.4 0.5 
Killip class 1.3 ± 0.7 1.2 ± 0.7 1.3 ± 0.7 0.2 
Cardiac enzymes (CKMB) 
CKMB 1 U/L 183 ± 148 185 + 159 183 ± 128 0.9 
CKMB 2 U/L (Peak) 262 ± 185 228 + 174 269 ± 186 0.04 
CKMB 3 U/L 195 ± 162 135 ± 114 208 ± 163 0.001 
Clinical characteristics of the studied population 
Total ischemic time /h 6.4 ± 3.3 6.5 ± 2.5 6.4 ± 2.8 0.5 
Procedure time /minute 42 + 21 44.1 + 16 41.3 + 22 0.1 
Glycoprotein IIb/IIIa inhibitor 
(patient, %) 
347 (57%) 78 (72%) 269 (53%) 0.001 
ST resolution ≥ 70% 296 (48.8%) 63 (58%) 233 (46%) 0.01 
No reflow  71 (11%) 7 (6.5%) 64 (12.8%) 0.04 
Primary PCI procedure data 
Stent diameter/mm 3.3 ± 1.4 2.7 ± 1.3 3.5 ± 1.3 0.3 
Stent length/mm 22.1 ± 9.1 19.9 ± 10.7 22.7 ± 8.7 0.01 
Stented segment/ mm 25.5 ± 14.4 22.5 ± 13.5 28.5 ± 15.2 0.001 
Stent pressure/ATM 13.4 ± 4.7 12.1± 6.2 13.6 ± 4.3 0.01 
No of stents 1.1 + 0.6 1.0 + 0.5 1.2 + 0.6 0.001 
BPM: beat per minute; MAP: mean arterial pressure; PDT: pain to door time. 
 
 
B) Thrombus score 
Thrombus score 5 was present (76% vs 37%, 
p = 0.001) while thrombus score 0 was (0% vs 78%, p 
0.001) in group I vs group II respectively Table 3. 
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Table 3: Angiographic findings 
 Group I Group II P value 
TIMI pre-procedure 
0 subjects / (%) 102 (95%) 402 (80.4%) 0.001 
I subjects / (%) 5 (4.6%) 31(6.2%) 
II subjects / (%) 0 (0%) 45 (9%) 
III subjects / (%) 0 (0%) 22 (4.4%) 
TIMI post procedure 
0 subjects / (%) 1 (0.9%) 11 (2.2%) 0.07 
I subjects / (%) 2 (1.8%) 13 (2.6%) 
II subjects / (%) 4 (3.7%) 39 (7.8%) 
III subjects / (%) 100 (93.4%) 437 (87.4%) 
Thrombus score 
0 0 (0%) 391 (78.2%) 0.001 
1  0 (0%) 10 (2%) 
2  4 (3.7%) 4 (0.8%) 
3  6 (5.6%) 18 (3.6%) 
4  15 (14%) 40 (8%) 
5  82 (76.6%) 37 (7.4%) 
MBG 
0 subjects / (%) 6 (5.6%) 51 (10.2%) 0.001 
I subjects / (%) 7 (6.5%) 85 (17%) 
II subjects / (%) 37 (34%) 195 (39%) 
III subjects / (%) 57 (53.2%) 169 (33.8%) 
 
B) Stent characteristics 
Stent diameter: mean values were (2.7 ± 1.3 
vs 3.5 ± 1.3 mm, p 0.3) while Stent length: mean was 
(19.9 ± 10 vs 22.7 ± 8 mm, p 0.01). Stented segment 
mean was (22.5 ± 13.5 vs 28.5 ± 15.2 mm, p 0.001). 
Stent number mean was (1 ± 0.5 vs 1.2 ± 0.6, p 
0.001) in group I vs group II respectively. 
 
 Major adverse cardiac and 
 cerebrovascular events (MACCE) 
I) in hospital MACCE 
In the hospital, MACCE was reported in 79 
subjects (13%) of total study group {9 (8.4%) vs 70 
subjects (14%), p 0.07} in group I vs group II 
respectively Table 4. 
Table 4: In Hospital MACCE 
 Group I 
Thrombectomy 
9 (8.4%) 
Group II 
Conventional 
70 (14%) 
P value 
Mortality subjects/(%) 9 (8.4%) 59 (11.8%)  
 
 
0.07 
(TVR) subjects / (%) (0%) 5 (4.3%) 
(MI) subjects / (%) (0%) 5(4.3%) 
(CVS) subjects / (%) (0%) 1(0.2%) 
MACCE: major adverse cardiac and cerebrovascular events; TVR: target vessel revascularization; MI: 
myocardial infarction; CVS: cerebrovascular stroke. 
 
II) Follow up MACCE after 1year 
Follow up MACCE after 1 year reported in 
{(5.6%) vs (16%), p 0.4} in thrombectomy vs 
conventional group respectively Table 5. 
Table 5: MACCE after 1year  
 Group I 
Thrombectomy 
6 (5.6%) 
Group II 
Conventional 
80 (16%) 
P value 
Mortality subjects/ (%) 3(2.8%) 55 (11%)  
 
 
0.4 
(TVR) subjects / (%) 3 (2.8 %) 21(4.2%) 
(MI) subjects / (%) 0(0%) 4(0.8%) 
(CVS) subjects / (%) 0(0%) 0(0%) 
MACCE: major adverse cardiac and cerebrovascular events; TVR: target vessel 
revascularization; MI: myocardial infarction; CVS: cerebrovascular stroke. 
 
Kaplan–Meier Estimates for 1-year MACCE 
As Shown in the cumulative hazard rates for 
MACCE (death from cardiovascular causes, recurrent 
myocardial infarction, TVR, and HF requiring 
hospitalization), Hazard ratio was non significantly 
lower in thrombectomy group (72.5; 95% CI, 45.2 to 
99.8; p = 0.8) vs (85.7; 95% CI, 36.9 to135; p = 0.8) in 
thrombectomy vs conventional group respectively. 
The rate of the net-benefit for outcome was similar in 
both groups Figure 1. 
 
Figure 1: Kaplan–Meier curve for 1-year MACCE 
  
Further Subgroups 
We did further sub-grouping according to 
thrombus burden (high thrombus burden ≥ 3 and low 
thrombus score ≤ 2), ischemia time (0-6 hrs. and 7-12 
hrs.), initial TIMI flow (TIMI ≤ 1 and Normal flow), then 
multi-regression analysis was done using forest plot 
assessment for patient outcome. 
B) High thrombus burden group showed 
a tendency in favour of thrombectomy. However, did 
not reach statistical; significance p = 0.2. 
C) Subjects with earlier ischemic time (0-
6 h) showed favour for thrombectomy. However, it did 
not reach statistical significance p = 0.09. 
D) In the group with initial TIMI ≤ 1 also 
showed preferential for thrombectomy without 
statistical significance p = 0.08 Figure 2. 
 
Figure 2: Forest plot in outcome in pre-specified groups 
 
 
Discussion 
 
The increase in thrombus burden is 
associated with higher mortality [16], [17] and manual 
aspiration thrombectomy has the potential to reduce 
the thrombus burden [18].
 
After the initial TAPAS [3]
 
trial showed an improvement in myocardial blush and 
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a reduction in mortality, and a meta-analysis of small 
trials [19]
 
also showed a reduction in mortality, routine 
manual thrombectomy became a class IIa treatment 
recommendation in the American and European 
Guidelines for STEMI 2013 [20]. Subsequently, 
however, more recent larger trials, such as TOTAL 
[21] (N = 10,732)
 
and TASTE [18]
 
(N = 7244), and a 
meta-analysis [22]
 
showed an increase in the risk of 
stroke with routine manual thrombectomy without any 
benefit in terms of MACCE. Consequently, in the 
updated AHA/ACC 2015 guidelines [23] manual 
thrombus aspiration was downgraded to a class IIb 
recommendation for the treatment of STEMI; in the 
2017 STEMI guidelines, it was further downgraded to 
a class III recommendation [24].  
 
Myocardial perfusion 
In our study, the thrombectomy group showed 
better ST segment resolution of ≥ 70% (58% vs 46%, 
respectively, p 0.001) in the thrombectomy group vs 
the conventional group.  
In our study, the peak CK-MB was lower in 
the thrombectomy group (228 ± 174 U/L vs 269 ± 186 
U/L, p = 0.04). This is in line with Orrego et al., (2006) 
[25]
 
who reported peak CK-MB values of (790 ± 
132U/L vs 910 ± 128 U/L, p = 0.0001) in the 
thrombectomy group vs the conventional group.  
 
Angiographic procedure 
The classic approach of pre-dilation before 
stent deployment and high-pressure post dilation is 
associated with increased procedure duration, more 
radiation exposure, contrast use, and increased costs 
compared with direct stenting [26], [27].  
In our study, direct stenting was more 
frequent in the thrombectomy group than the 
conventional group (38% vs 20%, p = 0.001). 
Rodriguez et al., (2014) [28] reported direct stenting 
rates of (58% vs 45% for the thrombectomy group vs 
the conventional group, p = 0.009).  
Yamaguchi et al., (2013) [29]
 
reported in an 
OCT study (n = 188), that thrombus aspiration before 
primary angioplasty in patients with STEMI was 
associated with significantly less tissue protrusion 
compared with standard PCI; it was also associated 
with favourably influenced lesion morphologies in the 
stented segment.
 
From this, we can state that 
thrombus aspiration can decrease clot volume, which 
causes a higher thrombus grade. 
 
 
Stent characteristics 
In-stent restenosis [30]
 
and stent thrombosis 
[31] is directly related to the characteristics of the 
stents [32]. Thus, the stent type [33] and the use of 
fewer stents and stents with a larger diameter [34] and 
a smaller length [33], [34] during STEMI could have 
long-term prognostic implications by reducing stent 
restenosis and stent thrombosis. 
Certain stent characteristics have been 
associated with stent restenosis [35],
 
including stent 
length [36]
 
and stent diameter [37].
 
In the present 
study, the mean stent diameter was (2.7 ± 1.3 vs 3.5 ± 
1.3 mm, p = 0.3), while the stent length was 
significantly shorter in the thrombectomy group (19.9 
± 10 vs 22.7 ± 8 mm, p = 0.01). Also, the mean length 
of the stented segments was significantly lower in the 
thrombectomy group than in the conventional group 
(22.5 ± 13 vs 28.5 ± 15 mm, respectively, p = 0.001). 
Along the same line, Rodriguez et al., (2014) [28] 
reported a mean length of stented segments of (24.1 
± 11.8 vs 26.9 ± 15.7 mm, p = 0.03). In the current 
study, the thrombectomy group required fewer stents 
(1 ± 0.5 vs 1.2 ± 0.6, p = 0.001).  
Multiple factors likely contribute to no-reflow. 
These include distal embolisation of a plaque and/or 
thrombus, microvascular damage, myocardial 
necrosis and stunning [38].
 
Other studies have noted 
a higher rate of adverse outcomes in patients with no 
reflow, regardless of the method of detection. These 
adverse outcomes include increases in in-hospital 
heart failure and mortality, left ventricular remodelling 
at six months, and mortality at one year [39], [40].
 
In 
the current study, the incidence of no-reflow was 
significantly lower in the thrombectomy group than in 
the conventional group {7 subjects (6.5%) vs 64 
(12.8%), p = 0.04}. These findings are in line with 
those of the study by Orrego et al., (2006) [25], who 
reported that the incidence of no-reflow was 
significantly lower in the thrombectomy group than in 
the conventional group (3% vs 15%, respectively, p = 
0.02). 
 
MACCE 
In our study, the rate of in-hospital MACCE 
was higher in the conventional group, although the 
difference did not reach statistical significance {9 
(8.4%) vs 70 patients (14%), p = 0.07}. In comparison, 
follow-up MACCE after 1 year was reported in {6 
subjects (5.6%) vs 80 (16 %), p = 0.4} in the 
thrombectomy group vs the conventional groups. This 
is in line with the updated meta-analysis by Ghatak et 
al., (2015) [41], which included 21,281 patients in 20 
trials and reported no difference in mortality, recurrent 
MI, target vessel revascularization, early or late stent 
thrombosis, or net clinical benefit between 
thrombectomy and conventional PPCI patients during 
short-term or long-term follow-up. Conversely, a 
previous meta-analysis by Kumbhani et al., (2013) 
[42] that included 18 trials reported that manual 
thrombus aspiration was associated with a reduction 
in major adverse cardiac events, including mortality at 
6 to 12 months, but had a trend towards a higher risk 
of stroke. In our study, CVS developed in one patient 
in the conventional group, who also developed 
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paroxysmal AF; consequently, we cannot provide a 
comment regarding CVS. Of note, the TOTAL trial [21] 
reported that the thrombectomy group showed 
significant development of CVS compared with the 
conventional group (0.7% vs 0.3%, p = 0.02). Recent 
data suggest that thrombus aspiration may be 
associated with stroke [43], [44]. This was not 
demonstrated in other single-country studies [45], [46]
 
raising the question of whether technique may play a 
role. Possible explanations for the association 
between stroke and thrombus aspiration include 
catheter-induced embolization of the thrombus into 
the systemic vasculature; aggressive guide catheter 
manipulation to pass the aspiration catheter, which 
dislodges aortic atheroma; and longer procedure 
times arising from the aspiration procedure [47].  
  
Study Limitations 
- This is a single-centre, some information of 
interest, such as data on the duration of diabetes 
mellitus ischemic heart disease, were missing. 
- The treating physician was aware of the 
group to which the patients had been assigned. 
- Myocardial blush grade assessment requires 
waiting approximately 5 seconds post-dye injection for 
proper evaluation, which was not possible for all 
patients.  
- MACCE were assessed after 12 months 
post discharge. The data were collected by outpatient 
follow-up, record reviews, and direct contact or phone 
calls with the patients or their relatives. 
In patients with STEMI subjected to PPCI with 
thrombus score ≥ 3: 
- Thrombus aspiration before primary PCI 
improves myocardial perfusion, as indicated by the 
findings of better ST-segment resolution and TIMI flow 
and reduced peak CKMB and MBG. 
- Thrombus aspiration before primary PCI was 
associated with a higher rate of direct stenting, shorter 
stent length, fewer stented segments and fewer 
stents. 
- Despite the greater risk associated with the 
pre-procedure thrombus score in the thrombectomy 
group, there was no difference in MACCE.  
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